药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cefotetan
Cangrelor
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Cangrelor.
Cefotetan
Idraparinux
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Idraparinux.
Cefotetan
Semuloparin
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Semuloparin.
Cefotetan
Sulodexide
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sulodexide.
Cefotetan
Prasugrel
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Prasugrel.
Cefotetan
Fibrinolysin
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Fibrinolysin.
Cefotetan
Beraprost
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Beraprost.
Cefotetan
Ancrod
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ancrod.
Cefotetan
Defibrotide
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Defibrotide.
Cefotetan
Desmoteplase
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Desmoteplase.
Cefotetan
Ximelagatran
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ximelagatran.
Cefotetan
Coumarin
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Coumarin.
Cefotetan
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with 4-hydroxycoumarin.
Cefotetan
Tibolone
Tibolone may increase the anticoagulant activities of Vorapaxar.
Cefotetan
Sugammadex
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sugammadex.
Cefotetan
Ibrutinib
The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Vorapaxar.
Cefotetan
Edoxaban
The risk or severity of bleeding can be increased when Edoxaban is combined with Vorapaxar.
Cefotetan
Deferasirox
The risk or severity of gastrointestinal bleeding can be increased when Vorapaxar is combined with Deferasirox.
Cefonicid
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Ledipasvir.
Cefonicid
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Ledipasvir.